Bio-Connect

ERK1 (phospho Thr202/Tyr204) + ERK2 (phospho Thr185/Tyr187) antibody [MAPK-YT]

Research Use Only
GTX01452
GeneTex
ApplicationsImmunoFluorescence, Western Blot, ImmunoCytoChemistry, ImmunoHistoChemistry, ImmunoHistoChemistry Paraffin
Product group Antibodies
ReactivityHuman, Mouse, Rat, Yeast
TargetMapk3
Sign in to order and to see your custom pricing.
Large volume orders?
Order with a bulk request

Overview

  • Supplier
    GeneTex
  • Product Name
    ERK1 (phospho Thr202/Tyr204) + ERK2 (phospho Thr185/Tyr187) antibody [MAPK-YT]
  • Delivery Days Customer
    9
  • Antibody Specificity
    Superfamily members of Mapk3 are not reactive to this antibody.
  • Application Supplier Note
    WB: 0.25-0.5microg/ml. ICC/IF: 1microg/ml. IHC-P: 0.4-1microg/ml. *Optimal dilutions/concentrations should be determined by the researcher.Not tested in other applications.
  • Applications
    ImmunoFluorescence, Western Blot, ImmunoCytoChemistry, ImmunoHistoChemistry, ImmunoHistoChemistry Paraffin
  • Certification
    Research Use Only
  • Clonality
    Monoclonal
  • Clone ID
    MAPK-YT
  • Conjugate
    Unconjugated
  • Formulation
    Liquid
  • Gene ID50689
  • Target name
    Mapk3
  • Target description
    mitogen activated protein kinase 3
  • Target synonyms
    ERK1; Erk-1; ERT2; Esrk1; extracellular signal-regulated kinase 1; insulin-stimulated MAP2 kinase; MAP kinase 1; MAP kinase 3; MAPK 1; MAPK 3; MAPK1; microtubule-associated protein 2 kinase; mitogen-activated 3; mitogen-activated protein kinase 1; mitogen-activated protein kinase 3; MNK1; p44; p44erk1; p44mapk; Prkm3
  • Host
    Mouse
  • Isotype
    IgG1
  • Modification Type
    Phosphorylated
  • Protein IDP21708
  • Protein Name
    Mitogen-activated protein kinase 3
  • Reactivity
    Human, Mouse, Rat, Yeast
  • Storage Instruction
    -20°C or -80°C,2°C to 8°C
  • UNSPSC
    12352203

References

  • Phosphorylated AKT1 is associated with poor prognosis in esophageal squamous cell carcinoma. Zhu Z et al., 2015 Sep 4, J Exp Clin Cancer Res
    Read more
  • Phosphorylated ERK is a potential predictor of sensitivity to sorafenib when treating hepatocellular carcinoma: evidence from an in vitro study. Zhang Z et al., 2009 Aug 24, BMC Med
    Read more